Why EXEL? Exelixis, Inc. Analysis, Price & AI Insights | Whystock
EXEL
$48.70+4.28 (+9.64%)
After Hours$48.58-0.12 (-0.25%)· Last close May 6
Exelixis, Inc., an oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.